Positive results we announced today from a planned overall survival (OS) interim analysis of the Phase 3 head-to-head ENDEAVOR trial, with the study meeting the key secondary endpoint of OS, demonstrating that patients with relapsed or refractory multiple...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2mAUNz2
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Background Hyperthyroidism is associated with increased thrombotic risk. As contact system activation through formation of neutrophil extrac...
-
Abstract Ocean acidification increases the amount of dissolved inorganic carbon (DIC) available in seawater which can benefit photosynthes...
-
Inhibition of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) signaling is highly effective in a subgroup of no...
-
Abstract Diphenylarsinic acid (DPAA) is an organic arsenic compound used for the synthesis of chemical weapons. We previously found that th...
-
Pugazhenthan Thangaraju, Sajitha Venkatesan, MK Showkath Ali Indian Journal of Community Medicine 2018 43(1):58-59 from #AlexandrosSfa...
-
IJMS, Vol. 18, Pages 1601: Updated Insight into the Physiological and Pathological Roles of the Retromer Complex International Journal of M...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου